Miller Value Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $241K | Hold |
|
|||||
|
2024
Q3 | $197K | Hold |
|
|||||
|
2024
Q2 | $178K | Sell |
|
|||||
|
2024
Q1 | $164K | Sell |
|
|||||
|
2023
Q4 | $140K | Sell |
|
|||||
|
2023
Q3 | $145K | Sell |
|
|||||
|
2023
Q2 | $618K | Sell |
|
|||||
|
2023
Q1 | $34.8M | Sell |
|
|||||
|
2022
Q4 | $46.9M | Sell |
|
|||||
|
2022
Q3 | $74.7M | Sell |
|
|||||
|
2022
Q2 | $70.2M | Sell |
|
|||||
|
2022
Q1 | $94.5M | Buy |
|
|||||
|
2021
Q4 | $77.4M | Sell |
|
|||||
|
2021
Q3 | $94.9M | Sell |
|
|||||
|
2021
Q2 | $108M | Buy |
|
|||||
|
2021
Q1 | $122M | Buy |
|
|||||
|
2020
Q4 | $68.9M | Sell |
|
|||||
|
2020
Q3 | $72.9M | Buy |
|
|||||
|
2020
Q2 | $96.8M | Sell |
|
|||||
|
2020
Q1 | $71.1M | Sell |
|
|||||
|
2019
Q4 | $96.4M | Buy |
|
|||||
|
2019
Q3 | $58.4M | Buy |
|
|||||
|
2019
Q2 | $60M | Buy |
|
|||||
|
2019
Q1 | $71.2M | Buy |
|
|||||
|
2018
Q4 | $60.3M | Buy |
|
|||||
|
2018
Q3 | $84.1M | Buy |
|
|||||
|
2018
Q2 | $63M | Buy |
|
|||||
|
2018
Q1 | $37.5M | Buy |
|
|||||
|
2017
Q4 | $9.78M | Buy |
|